Enhanced Reendothelialization and Thrombosis Prevention with a New Drug-Eluting Stent
Cardiovascular Drugs and Therapy · 2025-08 · 39 (4) · 765-774
DOI: 10.1007/s10557-024-07584-y ↗Kurz gefasst
Fachartikel in der Zeitschrift Cardiovascular Drugs and Therapy, online erschienen am 04.06.2024. Verfasst von Dunpeng Cai und 5 weiteren Autor:innen. Beteiligte Einrichtung: Departments of Surgery, University of Missouri School of Medicine, 1 Hospital Drive, Columbia, MO, 65212, USA. Hauptthemen laut MEDLINE: Drug-Eluting Stents, Thrombosis. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 29 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NHLBI NIH HHS, BLRD VA, American Heart Association.
Abstract (Originalsprache)
PURPOSE: The objective of the study is to test the efficacy of cyclopentenyl cytosine (CPEC)-coated stents on blocking artery stenosis, promoting reendothelialization, and reducing thrombosis. METHODS: Scanning electron microscopy was employed to observe the morphological characteristics of stents coated with a mixture of CPEC and poly(lactic-co-glycolic acid) (PLGA) copolymer. PLGA has been used in various Food and Drug Administration (FDA)-approved therapeutic devices. In vitro release of CPEC was tested to measure the dynamic drug elution. Comparison between CPEC- and everolimus-coated stents on neointimal formation and thrombosis formation was conducted after being implanted into the human internal mammary artery and grafted to the mouse aorta. RESULTS: Optimization in stent coating resulted in uniform and consistent coating with minimal variation. In vitro drug release tests demonstrated a gradual and progressive discharge of CPEC. CPEC- or everolimus-coated stents caused much less stenosis than bare-metal stents. However, CPEC stent-implanted arteries exhibited enhanced reendothelialization compared to everolimus stents. Mechanistically, CPEC-coated stents reduced the proliferation of vascular smooth muscle cells while simultaneously promoting reendothelialization. More significantly, unlike everolimus-coated stents, CPEC-coated stents showed a significant reduction in thrombosis formation even in the absence of ongoing anticoagulant treatment. CONCLUSIONS: The study establishes CPEC-coated stent as a promising new device for cardiovascular interventions. By enhancing reendothelialization and preventing thrombosis, CPEC offers advantages over conventional approaches, including the elimination of the need for anti-clogging drugs, which pave the way for improved therapeutic outcomes and management of atherosclerosis-related medical procedures.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Departments of Surgery, University of Missouri School of Medicine, 1 Hospital Drive, Columbia, MO, 65212, USA.
- The Research Service, Harry S. Truman Memorial Veterans Hospital, Columbia, MO, 65212, USA.
- Department of Medicine, University of Missouri School of Medicine, Columbia, MO, 65212, USA.
- Departments of Surgery, University of Missouri School of Medicine, 1 Hospital Drive, Columbia, MO, 65212, USA. scqvd@missouri.edu.
- The Research Service, Harry S. Truman Memorial Veterans Hospital, Columbia, MO, 65212, USA. scqvd@missouri.edu.
ORCID-Profile: Shi-You Chen
Förderung
- NHLBI NIH HHS
- BLRD VA
- American Heart Association
- National Heart, Lung, and Blood Institute
- U.S. Department of Veterans Affairs
Zitieren
APA
Cai, D., Chen, A. C., Zhou, R., Murashita, T., Fay, W. P., & Chen, S. Y. (2025). Enhanced Reendothelialization and Thrombosis Prevention with a New Drug-Eluting Stent. Cardiovascular Drugs and Therapy, 39(4), 765-774. https://doi.org/10.1007/s10557-024-07584-y
Vancouver
Cai D, Chen AC, Zhou R, Murashita T, Fay WP, Chen SY. Enhanced Reendothelialization and Thrombosis Prevention with a New Drug-Eluting Stent. Cardiovascular Drugs and Therapy. 2025;39(4):765-774. doi:10.1007/s10557-024-07584-y
BibTeX
@article{Cai2025,
author = {Cai, Dunpeng and Chen, Andy C and Zhou, Ruimei and Murashita, Takashi and Fay, William P and Chen, Shi-You},
title = {Enhanced Reendothelialization and Thrombosis Prevention with a New Drug-Eluting Stent},
journal = {Cardiovascular Drugs and Therapy},
year = {2025},
volume = {39},
number = {4},
pages = {765--774},
doi = {10.1007/s10557-024-07584-y}
}
EUVIMED